JAK Inhibitors in Atopic Dermatitis Associated With Risk of Viral Infections: A Critical Appraisal

被引：2
|
作者：
Pathania, Y. S. [1 ]
机构：
[1] All India Inst Med Sci, Dept Dermatol Venereol & Leprol, Rajkot, Gujarat, India
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2023年 / 114卷 / 03期
关键词：
GUIDELINE; ADULTS;
D O I：
10.1016/j.ad.2022.03.025
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：277 / 278
页数：2
相关论文
共 50 条
  • [31] The efficacy of Janus Kinase (JAK) inhibitors in treating atopic dermatitis: a systematic review
    Arora, C. J.
    Shumack, S.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 23 - 24
  • [32] JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerations
    Kopelman, Hannah
    Kontzias, Christina
    Alihosseni, Christopher
    Feldman, Steven R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (08) : 537 - 542
  • [33] JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse events
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 324 - 325
  • [34] Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors
    Kirchhof, Mark G.
    Prajapati, Vimal H.
    Gooderham, Melinda
    Hong, Chih-ho
    Lynde, Charles W.
    Maari, Catherine
    Turchin, Irina
    Papp, Kim A.
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2653 - 2668
  • [35] Reasons for the different frequencies of cutaneous viral infections in atopic dermatitis and psoriasis
    Wolk, K.
    Witte, K.
    Witte, E.
    Raftery, M.
    Kokolakis, G.
    Warszawska, K.
    Kirsch, S.
    Philipp, S.
    Schoenrich, G.
    Volk, H.
    Sterry, W.
    Sabat, R.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (03) : E20 - E20
  • [36] Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections
    Berdyshev, Evgeny
    Goleva, Elena
    Bronova, Irina
    Bronoff, Anna Sofia
    Streib, Joanne E.
    Vang, Kathryn A.
    Richers, Brittany N.
    Taylor, Patricia
    Beck, Lisa
    Villarreal, Miguel
    Johnson, Keli
    David, Gloria
    Slifka, Mark K.
    Hanifin, Jon
    Leung, Donald Y. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (03) : 640 - 648
  • [37] CARE OF THE PEDIATRIC PATIENT WITH ATOPIC DERMATITIS AND SECONDARY BACTERIAL AND VIRAL INFECTIONS
    Oehlke, Sandra
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2016, 43 (03) : S26 - S26
  • [38] A case report and critical appraisal of the literature on the use of DermaSilk® in children with atopic dermatitis
    Vlachou, C.
    Thomas, K. S.
    Williams, H. C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (08) : E901 - E903
  • [39] Health-Related Quality of Life Measures in Atopic Dermatitis: A Critical Appraisal
    Apfelbacher C.
    Heinl D.
    Current Dermatology Reports, 2015, 4 (4) : 155 - 158
  • [40] JAK inhibitors and infections risk: focus on herpes zoster
    Sunzini, Flavia
    McInnes, Iain
    Siebert, Stefan
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
12345